ADINOS GEN

This brand name is authorized in Brazil

Active ingredients

The drug ADINOS GEN contains a combination of these active pharmaceutical ingredients (APIs):

1 Desonide
UNII J280872D1O - DESONIDE

Desonide is a low-potency topical corticosteroid. Corticosteroids play a role in cellular signaling, immune function, inflammation, and protein regulation; however, the precise mechanism of action in the treatment of atopic dermatitis is unknown.

Read about Desonide
2 Gentamicin
UNII 8X7386QRLV - GENTAMICIN SULFATE

Gentamicin is usually bactericidal in action. Although the exact mechanism of action has not been fully elucidated, the drug appears to inhibit protein synthesis in susceptible bacteria by irreversibly binding to 30S ribosomal subunits.

Read about Gentamicin

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
D07BB02 Desonide and antiseptics D Dermatologicals → D07 Corticosteroids, dermatological preparations → D07B Corticosteroids, combinations with antiseptics → D07BB Corticosteroids, moderately potent, combinations with antiseptics
Discover more medicines within D07BB02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: BR Cรขmara de Regulaรงรฃo do Mercado de Medicamentos Identifier(s): 500514801176311, 500514802172318, 500514803179316, 500514804175314

ยฉ All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.